Lessons Learned from 1,000 Neobladders: the 90-day Complication Rate
Overview
Affiliations
Purpose: We report the 90-day morbidity of the ileal neobladder in a large, contemporary, homogenous series of patients who underwent radical cystectomy at a tertiary academic referral center using a standard approach.
Materials And Methods: Between January 1986 and September 2008 we performed 1,540 radical cystectomies. A total of 281 patients had an absolute contraindication for orthotopic reconstruction. The remaining 1,259 patients were candidates for a neobladder. Of these patients 1,013 (66%) finally received a neobladder and form the basis of this report. All patients had a thorough followup until December 2008 or until death. All complications within 90 days of surgery were defined, categorized and classified by an established 5 grade and 11 domain modification of the original Clavien system.
Results: Of 1,013 patients 587 (58%) experienced at least 1 complication within 90 days of surgery. Infectious complications were most common (24%) followed by genitourinary (17%), gastrointestinal (15%) and wound related complications (9%). The 90-day mortality rate was 2.3%. Of the patients 36% had minor (grade 1 to 2) and 22% had major (grade 3 to 5) complications. On univariate analysis the incidence and severity of the 90-day complications rate correlate highly significantly with age, tumor stage, American Society of Anesthesiologists score and preoperative comorbidity.
Conclusions: Radical cystectomy and ileal neobladder formation represent a major surgery with potential relevant early complications even in the most experienced hands. The rate of severe and lethal complications is acceptably low.
Lipowski P, Ostrowski A, Adamowicz J, Jasiewicz P, Kowalski F, Drewa T Cancers (Basel). 2025; 17(1.
PMID: 39796730 PMC: 11720066. DOI: 10.3390/cancers17010102.
Kilz J, Sidoti Abate M, Wieland V, Egen L, Haney C, Antoniewicz A Eur Urol Open Sci. 2025; 71:78-86.
PMID: 39758853 PMC: 11697608. DOI: 10.1016/j.euros.2024.11.003.
Clinical efficacy and safety of organ-sparing cystectomy: a systematic review and meta-analysis.
Zhang Y, Peng L, Zhang Y, Li H, Li S, Zhang S PeerJ. 2024; 12:e18427.
PMID: 39677963 PMC: 11639212. DOI: 10.7717/peerj.18427.
Wang H, Huang H, Hao H, Xi Z Front Oncol. 2024; 14:1453346.
PMID: 39650069 PMC: 11621080. DOI: 10.3389/fonc.2024.1453346.
Sighinolfi M, Calcagnile T, Panio E, Assumma S, Sarchi L, Sandri M Clin Pract. 2024; 14(5):1790-1800.
PMID: 39311293 PMC: 11417726. DOI: 10.3390/clinpract14050143.